drugset / Trial / NCT00626600

A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion

NCT00626600

Phase 3 Terminated 33 enrolled Mundipharma Research Limited
RandomizedSingle-groupOpen-labelTreatment

Summary

Assessing the safety and tolerability of Oxycodone Hydrochloride 50mg/mL in subjects with severe cancer pain.

Timeline

Start
2008-05
Primary completion
2009-05
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 50 mg/ml Subcutaneous

Indications

No indication recorded.